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In July, 2012 three isolations were made from mosquitoes collected in Brazoria, Orange and Montgomery
counties, Texas, USA. Data from immunoﬂuorescence testing suggested that these isolates are members
of the genus Orthobunyavirus. Expanded analyses conﬁrmed that these isolates comprise three
independent isolations of the same virus; a novel orthobunyavirus. The genetic organization of the M
and L segments of this virus is similar to that of other orthobunyaviruses. However, the S segment
(∼1.7 kb) is nearly twice the length of known orthobunyavirus S segments, encoding a signiﬁcantly larger
nucleocapsid, N (∼50 kDa) and putative non-structural NSs (∼20 kDa) proteins in a novel strategy by
which the NSs ORF precedes the N ORF. The N protein appears to consist of two functional domains; an
amino portion that possesses motifs similar to other orthobunyavirus N proteins and a carboxyl portion
that possesses a glutamine-rich domain with no known homologue among Bunyaviridae.
Published by Elsevier Inc.Introduction
The virus family Bunyaviridae is remarkably diverse with
greater than 350, predominantly arthropod-borne viruses
described as members and susceptible hosts spanning both animal
and plant kingdoms. Bunyaviruses are classiﬁed into ﬁve genera,
the Orthobunyavirus, Phlebovirus, Nairovirus, Hantavirus and Tos-
povirus genera according to antigenic, structural and genetic
features. A distinguishing feature of the family, bunyaviruses
possess a single stranded, negative-sense RNA genome that is
comprised of three segments, L, M and S that generically encode
the polymerase, envelope glyco- and nucleocapsid proteins,
respectively. It is this segmented genome that allows bunyaviruses
to evolve through segment reassortment or “antigenic shift”; a
phenomenon that has been well documented and associated with
outbreaks of human illness (Beaty et al., 1985; Borucki et al., 1999;
Bowen et al., 2001; Gerrard et al., 2004; Briese et al., 2006). In
recent years, there has been a growing number of newly described
bunyaviruses such as Schmallenberg, severe fever with thrombo-
cytopenia syndrome (SFTS), and Heartland viruses that haveInc.
v (R.S. Lanciotti).emerged as animal and human pathogens in Europe, Asia and
North America, respectively, (Hoffmann et al., 2011; Yu et al., 2011;
McMullan et al., 2012). These events underscore the extraordinary
evolutionary potential and likely underestimation of Bunyaviridae
worldwide.
The genus Orthobunyavirus is the largest within the family
Bunyaviridae with over 160 described members and a geographic
range that encompasses tropical (i.e., Group C viruses), temperate
(i.e., La Crosse and Jamestown Canyon viruses) and arctic (i.e.,
Inkoo and Northway viruses) ecologies. The majority of orthobu-
nyaviruses are transmitted by mosquitoes with small mammals
generally serving as amplifying hosts. Approximately 25 orthobu-
nyaviruses have been associated with human illnesses that can be
characterized by severe clinical outcomes, such as pediatric
encephalitis that is associated with La Crosse virus infections
within North America. Most orthobunyaviruses are classiﬁed
within 18 traditional serogroups, some of which represent sub-
groups of the four most well described serogroups that are known
to possess human and animal pathogens, the Bunyamwera, Cali-
fornia, Simbu and Group C groups. The orthobunyavirus genome
entails a distinctive coding strategy, with particular regard to the S
segment (∼900 nt) that possesses an overlapping ORF, whereby a
relatively small non-structural protein, NSs (∼10 kDa) is encoded
by an independent ORF with a start codon that lies at a+1 shifted
1.E+07
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protein, N (∼25 kDa). For representative viruses of the California
and Bunyamwera serogroups, the NSs protein has been shown to
possess anti-host cellular mRNA and protein synthesis attributes
that act to prevent the host interferon response (Bridgen et al.,
2001; Kohl et al., 2003; Blakqori et al., 2007; Weber et al., 2002).
The N protein plays the primary role in the encapsidation of viral
RNA and the formation of the ribonucleocapsid protein complex,
an interaction that is fundamental to virus replication and
viability.
As part of ongoing arbovirus surveillance efforts, in July of 2012
three pools of Culex species mosquitoes were collected within a
period of days from Brazoria, Montgomery and Orange counties,
within and surrounding the Greater Houston Area of Texas, USA,
respectively. From these pools, three virus isolates were derived by
Vero cell culture at the Texas State Department of Health. Each
isolate was preliminarily identiﬁed as an orthobunyavirus by “dull”
reactivity with anti-bunyavirus polyclonal serum in immunoﬂuor-
escence assays. Subsequently, these isolates were sent to the
Centers for Disease Control and Prevention (CDC) in Fort Collins,
Colorado for further identiﬁcation. Upon receipt at the CDC, the
isolates tested negative for a diversity of known orthobunyaviruses
using a battery of consensus RT-PCR assays. Consequently, the
isolates were evaluated by next generation sequencing (NGS) and
determined to be isolates of the same virus that was previously
undescribed at the molecular level. Resultant data and expanded
analyses indicate that this virus, with the proposed name of
“Brazoran” virus after the ﬁrst two counties of origin from which
positive mosquitoes were collected (Braz-oria+Oran-ge), repre-
sents the sole known member of a unique lineage and serogroup
within the genus Orthobunyavirus of the family Bunyaviridae.
Here, we provide a basic biological, molecular and serological
description of the newly isolated Brazoran virus. A particular focus
of our research, at approximately 1.7 kb in length, the S segment of
Brazoran virus is entirely distinct and does not possess the
canonical overlapping ORF of the genus. Speciﬁcally, while they
share motifs common to the N and NSs proteins, the size and
composition of the proteins encoded therein have no known near
equivalents among all other members of Bunyaviridae for which
there are available genetic data.1.E+00
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Fig. 1. Growth of Brazoran virus in Vero, Vero E6, LLC-MK2, BHK, C6/36, and Culex
quinquefasciatus cell lines. Vero, Vero E6, and LLC-MK2 cell monolayers were
completely lysed by day 3, ending data collection from these cell types. Vero and
LLC-MK2 data points completely overlap and are indistinguishable in this ﬁgure.
Virus titers were estimated by real time RT-PCR and standard curve calculations
(see text) and several titer data points were conﬁrmed by conventional plaque
titration. Peak viremia values are displayed adjacent to the data point for all cell
systems.Results
Growth of Brazoran virus in mammalian and mosquito cell lines
Brazoran virus displayed rapid growth to high titers in the
three primate derived cell lines (Vero, Vero E6, and LLC-MK2 cells;
Fig. 1). Typical cytopathic effects were clearly visible in these three
cell types as early as 24 h post infection, and the cell monolayers
were completely lysed by 3 days post infection. The virus titer
reached approximately 106.7 pfu/ml for these cell types by day 3.
BHK cells demonstrated slower growth characteristics with very
limited CPE observed, reaching a maximum titer of 105.8 by day 7.
No CPE was observed in both of the mosquito cell lines used and
growth was both slower and maximum titers were signiﬁcantly
lower by 2–3 log10 when compared to the primate derived cell
lines. Brazoran virus was re-isolated in Vero cells from the original
mosquito pool homogenates and growth characteristics were
similar (CPE at day 5; data not shown) to that described by the
TDSHS laboratory.
Two-way plaque reduction neutralization analysis of Brazoran virus
To determine possible serological relationships between
Brazoran virus and other members of the family Bunyaviridae,reference mouse polyclonal antisera directed against selected
viruses within various serogroups of the genus Orthobunyavirus
were tested for their ability to neutralize Brazoran virus in the
PRNT assay. In addition, broadly reactive antisera that were
prepared against viruses from other genera within the Bunyavir-
idae family were also utilized in the PRNT assay. As is shown in
Table 2a and 2b, none of the reference antisera demonstrated any
neutralizing activity against Brazoran virus and none of the tested
viruses were neutralized by Brazoran antibody.Nucleic acid sequence analysis of Brazoran virus L segment
The size of the L segment was determined to be 6911 bases
(Table 3). 6712 bases, from positions 171 to 6882, were derived
from a single contiguous sequence (contig) constructed by de novo
sequence assembly (all sequence position referenced throughout
are given in the plus/message sense of the RNA). The 5′ (170 bases)
and 3′ (29 bases) ends were determined by the RACE sequencing
protocols described in Materials and methods. The 5′ and 3′
terminal seven nucleotides are perfectly conserved on all three
segments with the consensus sequence AGTAGTG found in ortho-
bunyavirus, although differences with respect to published ortho-
bunyavirus sequences are found beyond position seven. A single
open reading frame, from positions 45 to 6741, codes for a 2246
amino acid protein with a predicted molecular weight of 261 kDa.
Analysis of the complete L sequence in both orientations revealed
no other open reading frames capable of coding for protein larger
than 83 amino acids. InterProScan analysis of the 2246 amino acid
protein revealed conserved family domains and functional motifs
found in orthobunyavirus RNA-dependent RNA polymerases. In
addition, protein BLAST analysis demonstrated sequence identity
with a number of orthobunyaviruses; the highest of which was a
66% sequence identity with Zungarachoa virus, a newly described
South American bunyavirus with some sequence similarities to
Group C and Simbu serogroup viruses (Hang et al., 2012). Taken
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Brazoran virus RNA-dependent RNA polymerase protein.
Nucleic acid sequence analysis of Brazoran virus M segment
The size of the M segment was determined to be 4659 bases
(Table 3). De novo assembly generated a contig starting at position
409 and ending at the 3′ end, including the 3′ terminal sequence.
The 5′ 408 bases were determined by the 5′ RACE sequencing
protocol and the 3′ terminal sequence was re-sequenced for
conﬁrmation using the 3′ RACE protocol. A single open reading
frame, from positions 59 to 4429, codes for a 1456 amino acid
protein with a predicted molecular weight of 165 kDa. Analysis of
the complete M sequence in both orientations revealed no other
open reading frames capable of coding for protein larger than 97
amino acids. InterProScan analysis of the this 165 kDa protein
revealed conserved family domains of the orthobunyavirus Gn,
NSm, and Gc proteins, occurring in this order on the M segment,
which is the standard order of proteins found in all characterized
orthobunyavirus M polyproteins. Analysis of this sequence for
conserved signal peptide cleavage sites suggests that the signal
peptide cleavage site occurs between amino acids 17 and 18,
indicating that the Gn protein begins at position 18. Comparison
to other orthobunyavirus protein sequence protease cleavage sites
suggests that the Gn protein terminates at position 301, the NSm
protein is from positions 302 to 515, and that Gn protein is from
positions 516 to 1456 (Table 3). The molecular weight decrease
observed with the Gn and Gc proteins after treatment to remove
N-linked sugars indicates that these viral glycoproteins are glyco-
sylated to some degree in the native virion; the number of
potential glycosylation sites utilized and their exact locations are
as yet undetermined. Mass spectrometry analysis of the protein
bands corresponding to the predicted migrations of Gn and Gc
from gradient puriﬁed virus conﬁrmed the presence and molecu-
lar weights of the Gn and Gc structural proteins (Table 3). Finally,
protein BLAST analyses of the translated M segment ORF (both full
length and truncated) revealed sequence identity with a number
of orthobunyaviruses, the greatest of which is an identity of ∼65%
with a 376 aa partial sequence that is available for Apeu virus of
the Group C serogroup (GenBank accession, ACZ65468). In sum-
mary, these data indicate that this 1456 aa protein is the Brazoran
virus polyprotein.
Nucleic acid sequence analysis of Brazoran virus S segment
The size of the S segment was determined to be 1672 nucleo-
tides in length (Table 3). De novo assembly generated a contig of
1665 nucleotides which spanned positions 7 to 1672 of the
complete S segment. The terminal ends were sequenced and/or
conﬁrmed by the RACE methods, as previously described. The ﬁrst
ORF begins at position 31 and ends with a stop codon (TAG) at
position 549, coding for a 172 amino acid protein with a predicted
molecular weight of 19.6 kDa (Table 3; Fig. 4A). Although BLAST
analysis found no signiﬁcant sequence identity matches for this
protein, analysis by InterProScan revealed conserved family
domains found within the orthobunyavirus NSs protein. A second
open reading frame shifted −1 with respect to the ﬁrst ORF, occurs
at position 72 and continues to a stop codon (TAA) at position
1400, coding for a 442 amino acid protein with a predicted
molecular weight of 49.8 kDa (Table 3; Fig. 4A). Protein BLAST
analysis revealed small regions of sequence identity with several
orthobunyavirus N proteins at ∼35%. Family domain analysis by
InterProScan and motif/domain analysis by MotifScan revealed
that this 442 aa sequence consisted of two functional domains.
The ﬁrst 240 amino acids possessed conserved motifs found in
other orthobunyavirus N proteins (Fig. 4B). Interestingly, theterminal 200 amino acids possess a glutamine-rich region proﬁle,
like those typically found in some eukaryotic transcription factors
(Table 3; Fig. 4B).
Because of the highly unusual observation of both the size and
coding strategy (NSs prior to N) of the S segment, two avenues
were used to conﬁrm these ﬁndings. First, a message sense viral
RNA of the complete S segment was constructed and tested in an
in vitro translation system to conﬁrm the size of the S segment
and to determine if both reading frames generated proteins. In
several experiments a 50 kDa protein was consistently observed,
no protein in the 20 kDa range was detected suggesting that either
the NSs protein was not synthesized or was synthesized at a lower
level (data not shown). It is however possible that the lack of
observation of this NSs protein may be an artifact of the biotiny-
lated lysine labeling system used; only seven lysine residues are
found in the NSs protein and this may not be sufﬁcient for
detection in this colorimetric system. Second, the 50 kDa protein
observed in SDS-PAGE analysis of viral proteins was excised and
subjected to mass spectrometry analysis where it was clearly
identiﬁed as the N protein through amino acid sequence matches
by 27 unique peptides spread throughout its entirety with nearly
60% complete protein coverage. This veriﬁes that the intact 50 kDa
protein is found in virus particles.
Phylogenetic analyses of the Brazoran virus S, M and L segments
Phylogenetic analyses of deduced amino acid sequences of the
S, M and L segment encoded nucleocapsid, glyco- and polymerase
proteins of diverse representatives of the genus Orthobunyavirus
along with members of the Hantavirus, Nairovirus and Phlebovirus
genera reveal generally distant evolutionary relationships between
Brazoran virus and other orthobunyaviruses (Fig. 3a–c). Within the
S segment phylogeny, for which there exists the most available
data in GenBank, Brazoran virus is shown to possess an indepen-
dent evolutionary history that is divergent from members of
described serogroups of the genus Orthobunyavirus, with the
exception of an apparently ancient association with African mem-
bers of the Tete serogroup (Batama and Tete viruses). In contrast,
within the M segment phylogeny, Brazoran appears in a well
supported grouping with the South American Apeu virus of the
Group C serogroup. However, as with the S segment phylogeny,
branch lengths suggest that this association is not recent. Similarly,
within the L segment phylogeny, Brazoran virus appears in well
supported groupings with a number of South American viruses
including Caraparu virus of the Group C serogroup as well as the
newly isolated Zungarococha virus of Peru. Also within the L
segment phylogeny, Brazoran virus is relatively distantly asso-
ciated with members of the Simbu serogroup, including Oro-
pouche virus. Taken together, these data suggest a common
ancestry between Brazoran virus and Group C and, more remotely,
Simbu serogroup viruses for the M and L segments.Discussion
Next generation sequencing technologies represent a signiﬁ-
cant improvement over traditional approaches (which require
prior nucleic acid sequence information) and, as evidenced in this
study, make possible the discovery of novel viruses. Of interest,
Brazoran virus was not detected by any of the broadly reactive
nucleic acid ampliﬁcation methods commonly used to identify
orthobunyaviruses, such as consensus RT-PCR utilizing primers
that target conserved orthobunyavirus sequences including the
terminal ends (Kuno, 1998; Lambert and Lanciotti, 2008, 2009). In
retrospect, it is apparent that these consensus primers failed to
amplify Brazoran virus due to signiﬁcant nucleotide sequence
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ods in testing ﬁeld-collected specimens, in this instance virus
isolation and immunoﬂuorescence (IFA), as opposed to relying
solely upon nucleic acid testing is also highlighted here. In this
case, testing collected mosquito pools by isolation and IFA sug-
gested the presence of an orthobunyavirus leading to further
studies, whereas screening isolates by RT-PCR only (which is a
common practice) clearly failed to detect the virus.
From an evolutionary perspective, data from serological, mole-
cular and phylogenetic analyses present a thought provoking
picture of Brazoran virus. Certainly, results from PRNT assays
suggest that Brazoran virus is serologically unique. However,
multi-segment phylogenetic analyses reveal distant, but well
supported and inconsistent associations between Brazoran virus
and viruses of the Tete, Group C and Simbu serogroups. While
results of these analyses strongly suggest a complex history for
Brazoran virus and are potentially reﬂective of an ancient segment
reassortment event, disparities in data availability among all three
segments limit deﬁnitive understanding in this regard. This short-
coming highlights the need for additional descriptive sequence
data for orthobunyaviruses of diverse description in all three
genomic segments.
Of special interest, the Brazoran virus S segment is signiﬁcantly
larger (1672 nt) than all known orthobunyavirus S segments
(∼900 nt) and is in fact more similar in size to the S segments of
phlebo-, nairo and hantaviruses (∼1.7 kb) which empirically sug-
gests an ancestral link between Brazoran virus and disparate
genera within Bunyaviridae. Furthermore, the Brazoran S segment
possesses a unique, previously undescribed coding strategy in
which the putative NSs ORF lies before that of the N protein. Of
note, viruses of the Anopheles A, B and Tete serogroups of the
genus Orthobunyavirus have also been shown to possess alter-
native coding strategies possessing only an N ORF and no NSs ORF
within their S segments (Mohamed et al., 2009). Furthermore, at
just over 1000 nt in length, the S segments of Batama and Tete
viruses are somewhat longer than typical orthobunyavirus S
segments providing additional, circumstantial evidence of relative
similarity that may corroborate phylogenetic and evolutionary
associations between Brazoran virus and viruses of the Tete
serogroup in the S segment.
The Brazoran virus putative NSs is signiﬁcantly larger
(19.6 kDa) than the typical orthobunyavirus NSs (∼10 kDa) yet
smaller than those of the Phlebovirus (∼30 kDa) and Tospovirus
genera (∼50 kDa). The NSs protein of bunyaviruses has been
shown to be an important virulence factor which suppresses host
cellular transcription (Bridgen et al., 2001; Kohl et al., 2003;
Blakqori et al., 2007; Weber et al., 2002). The fact that this protein
is encoded in the ﬁrst ORF suggests that it may be synthesized to a
higher level than NSs in other orthobunyaviruses, which could
alter virulence. Clearly, additional studies are needed to evaluate
the association of virulence to the position of this NSs gene on the
S segment. In vitro translation studies suggest that the N protein is
in fact synthesized to a much higher level than NSs however this
may be an artifact of the labeling method employed in these
studies. It is interesting to note that sequence analysis of the NSs
start codon region reveals a weak Kozak sequence, suggesting a
potential regulatory mechanism for down-regulating NSs synth-
esis compared to the N protein.
The N protein is perhaps the most unique and intriguing aspect
of Brazoran virus, both in terms of its size and in the discovery
of a glutamine-rich domain (GRD) at the carboxyl terminus.
Glutamine-rich domains are associated with protein-protein inter-
actions and are found in SP-family transcription factors (Suske,
1999). A GRD has also been described as a region within the HIV-1
Tat protein that is associated with apoptosis of infected cells
(Campbell et al., 2004). Of particular interest is the recentdescription of a proline/glutamine-rich domain host protein
shown to interact with the RNA-dependent RNA polymerase of
inﬂuenza virus which plays a key role in virus transcription
(Landeras-Bueno et al., 2011). The presence of a GRD found on a
viral structural protein that is synthesized to a very high degree is,
to the best of our knowledge, unprecedented. Of additional
interest, the amino (ﬁrst 240 aa) and carboxyl (last 202 aa)
portions of the Brazoran virus N protein are fundamentally
different in charge with calculated isoelectric points of 9.0 and
4.5, respectively, and an overall N protein Isoelectric point of 7.0.
Given the role of the N protein in ribonucleocapsid formation, it is
hypothesized that the Brazoran virus GRD and the unique proper-
ties of the carboxyl terminus may enhance protein complex
formation through interaction with the amino terminus of the N
protein. Further studies are clearly needed to elucidate any
virulence associated with this protein.
Finally, there remain several key questions concerning Bra-
zoran virus that need to be addressed in future studies. The ﬁrst
involves determining if human infections occur and if there exists
any association with human and/or veterinary disease. The limited
growth curves presented here, in which highest levels of replica-
tion were observed in primate cells, certainly suggests that
Brazoran virus can infect humans. Any association with disease
will need to be evaluated in future studies by incorporating
Brazoran virus in diagnostic serological assay algorithms; perhaps
starting with testing patients with undiagnosed viral infections in
areas geographically close to where these isolates were made.
Second, the question of the origin of Brazoran virus needs to be
addressed. Circumstantial evidence suggests a recent introduction
of this virus into the Houston area of Texas, possibly through
introduction via the Port of Houston. The TDSHS has used
essentially the same collection sites, frequency of collections, and
testing algorithms for the past 12 years. The fact that 3 isolates
were made within a period of days in July of 2012, and not in prior
years, certainly argues that Brazoran virus is new to Texas.Materials and methods
Virus isolations from mosquito collections
Three isolations of a suspected virus were made at the Texas
Department of State Health Services (TDSHS) laboratory in July
2012 from mosquito pools collected in Brazoria (7/13), Orange
(7/13), and Montgomery (7/16) Counties, Texas. The mosquitos
were collected as part of a routine arbovirus surveillance protocol
that has been in place since 2001 using CDC light traps placed in
the same general areas each year with approximately the same
collection frequency. The pools all consisted of mixed Culex species
mosquitoes (melanoconion, nigripalpus, salinarius) and were
ground in sterile buffered medium (BA-1) and inoculated into
Vero and BHK cells. CPE was observed 6–10 days post inoculation
only in Vero cells and an immunoﬂuorescence assay was per-
formed using a broadly reactive bunyavirus antiserum with “dull”
reactivity noted. The ﬁrst passage Vero isolates and the original
mosquito homogenates were shipped to the CDC, Arbovirus
Diagnostic Laboratory in Fort Collins, CO, USA for further analysis.
Cell culture, virus growth and puriﬁcation
All cell lines utilized in this study were obtained from the DVBD
cell culture core facility using optimal growth media for each cell
type. The Culex cell line utilized was obtained as a gift from the
University of Texas Medical Branch and was derived from Culex
quinquefasciatus mosquitoes. Brazoran virus was re-isolated from
the original mosquito homogenates using Vero cells. For Brazoran
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with the ﬁrst Vero passage isolate in duplicate T-25 ﬂasks at a
multiplicity of infection (m.o.i.) of 0.1 pfu/cell, incubated for 1 h at
371, followed by the removal of inoculum and replacement with
growth media. Aliquots (.05 ml) were removed at the time points
indicated (Fig. 1) and the virus quantity estimated using real time
ﬂuorescent probe based RT-PCR utilizing the standard curve
generated (Table 1; see below). Several aliquots were also tested
in parallel by standard plaque titration to validate this approach.
For large scale virus production and protein analysis, Brazoran
virus was grown in Vero cells using 10T-150 ﬂasks infected at a m.
o.i. of 0.1 pfu/ml. At 4 days post infection, the supernatant was
harvested and virus concentrated and puriﬁed according to
standard protocols using PEG 8000 precipitation, potassium tar-
trate/glycerol (K-TAR/GLYC) equilibrium gradient ultracentrifuga-
tion and the viral pellet resuspended in 0.2 ml of 0.1 M Tris buffer
pH 8 (Obijeski et al., 1974).
Two-way plaque reduction neutralization
For plaque reduction neutralization (PRNT) studies, approxi-
mately 100 pfu of Brazoran virus, or relevant control virus, was
incubated with serial dilutions of reference antibodies and then
inoculated onto Vero cells and plaques counted on day 4 according
to established protocols using 90% plaque reduction as the thresh-
old (Table 2a and 2b; Johnson et al., 2009). Brazoran virus
polyclonal antiserum was produced in 4 week old female CD-1
mice that were given intra-peritoneal injections of 104 pfu of
Brazoran virus diluted in sterile PBS. Terminal bleed and serum
collection was performed under Isoﬂurane sedation via cardiac
stick immediately followed by cervical dislocation. ReferenceTable 1
Primers and probes used for real time RT-PCR of Brazoran virus.
Segment Namea Positionb Sequence
L L3862f 3862–3869 TTTGCTGTCTCCAGGTTC
L L3971c 3971–3953 TTGTAGGAGAGTTGGAAGC
L L3911FAM 3911–3934 CTCTCCTTTGCAATTCGTTCCACT
M M2029f 2029–2048 AACGTTTCCTGGCATAGCTG
M M2187c 2187–2168 CCGTCTGCAACTGCTTTACA
M M2131FAM 2131–2155 TGGAGCAAAGGCTATCAAAGCAGCA
S S514f 514–531 TGCAAATTGGGTCCTGCT
S S670c 688–670 ACCAACCTCAGATCCAACT
S S548FAM 548–569 AACCTTGCTGTCTTGGGGCCAC
a FAM designation indicates 5′FAM labeled probe.
b L and S segment primer positions based upon negative genome sense; M
primers based upon plus message sense.
Table 2a
Two way neutralization results of Brazoran virus with representative viruses from
four orthobunyavirus serogroups and polyclonal antibodies directed against the
four serogroupsa.
Virus name strain Serogroup reactive antibody
BUNW CAL Simbu Group C BRAZ
Cache Valley 6V633 320 o20 o20 o20 o20
La Crosse Original o20 320 o20 o20 o20
Oropouche TR9760 o20 o20 40 o20 o20
Apeu BeAn 848 o20 o20 o20 2560 o20
Brazoran Original o20 o20 o20 o20 640
a The Bunyamwera (BUNW), California (CAL), Simbu, and Group C polyclonal
antibodies are grouping immune ﬂuids that were prepared against a number of
viruses within each serogroup. Brazoran (BRAZ) polyclonal antiserum is not a group
reactive antibody.antibodies used for neutralization include polyclonal antibodies
made against members of the four main serogroups of the genus
Orthobunyavirus, the Bunyamwera, California, Simbu and Group C
serogroups (Table 2a). In addition, neutralization tests were con-
ducted with a broad diversity of anti-bunyavirus antibodies
including those made against the Bwamba and Guama serogroups
of the genus Orthobunyavirus as well as the following NIH immune
grouping polyclonal antibodies, ANA, Group 1, Group 2, Group 3,
Group 12, CAP, CCHF and PHL (Table 2b). Viruses that NIH immune
grouping polyclonal antibodies were developed against include
the following. For the ANA group, antibodies were developed
against Anopheles A, Lukuni, Anopheles B, Boraciea, Tacaiuma,
CoAr 1071, CoAr 3624, Turlock, Umbre and M'poko viruses of the
Anopheles A, B and Turlock serogroups of the genus Orthobunya-
virus. For Group 1, antibodies were developed against Bahig, Tete
and Matruh viruses of the Tete serogroup of the Orhobunyavirus
genus as well as Matriya, EgAn 1398-61 and Burg El Arab viruses.
For Group 2, antibodies were developed against Alajuela and
Gamboa viruses of the Gamboa serogroup of the genus Orthobu-
nyavirus as well as the ungrouped Jurona and Belem viruses. For
Group 3, antibodies were developed against Koongol, Wongal,
Bakau and Ketapang viruses of the Koongal and Bakau serogroups
as well as Maprik, Mapputta and Trubanaman viruses of the
Mapputta antigenic complex. For Group 12, antibodies were
developed against Oliﬂantsvlei and Bobia viruses of the Oliﬂantsv-
lei serogroup of the genus Orthobunyavirus as well as the
ungrouped Okola, Witwatersrand and Tataguine viruses. For the
CAP group, antibodies were developed against viruses of the
Capim serogroup. Finally, the CCHF and PHL groups were included
as antibodies directed against serogroups of the Nairovirus and
Phlebovirus genera, respectively.
SDS-PAGE separation of puriﬁed viral proteins and protein
identiﬁcation by mass spectrometry
Gradient puriﬁed virus, prepared as described above, was
analyzed by electrophoresis in a novex 10–20% Tris-Glycine gel
run under reducing conditions. The virus proteins were electro-
phoresed either untreated or after de-glycosylation using a mix-
ture or ﬁve protein deglycosidases (PNGase F, O-glycosidase,
Neuraminidase, β1-4 Galactosidase, β-N-acetylglucosaminidase)
capable of removing glycans from both O-linked and N-linked
glycosylation sites(Promega). Proteins were visualized either by
silver staining using the SilverQuest kit (Invitrogen) or by coo-
massie blue staining using the Imperial stain (Thermo). Molecular
weights were estimated by comparing migration to protein
molecular weight standards (Fig. 2A). The major protein bands
were excised with a scalpel and shipped to the CDC Biotechnology
Core Facility, Mass Spectrometry and Proteomics Laboratory. The
protein bands were analyzed by nano-LC–MS/MS and proteins
were identiﬁed using Mascot Software (Matrix Science) querying
the NCBI database and a database consisting of the predicted
proteins of Brazoran virus derived by next generation sequencing
(Fig. 2B).
Next generation sequencing and analysis
Brazoran RNA was extracted and puriﬁed from 0.1 ml of
gradient puriﬁed virus using the QIAGEN QIAamp kit (Qiagen)
and resuspended in 0.1 ml of water. DNA libraries for NGS were
prepared using the NuGEN Ovation RNA-Seq System (Life Tech-
nologies) and the Ion Shear kit (Life Technologies). Brieﬂy, 5 μl of
RNA was reverse transcribed using the Ovation random primers
followed by second strand synthesis and SPIA ampliﬁcation
following the manufacturer's protocol. The resulting double
stranded DNA displayed an average size of 480 bp and was sheared
R.S. Lanciotti et al. / Virology 444 (2013) 55–6360to an average size of 230 bp by incubating with the Ion Shear
reagents for 10 min. Finally, adapter primers speciﬁc for the Ion
Torrent Personal Genome Machine (PGM, Life Technologies) wereTable 2b
Two way neutralization results of Brazoran virus with broad diversity of orthobunyavir
Virus name strain Bunyavirus antibodiesb
BWAa GMA ANA Group 1 G
Bwamba UgAr 1888 10240 o20 o20 o20 o
Guama BeAn 277 o20 640 o20 o20 o
Turlock RS 8127 o20 o20 160 o20 o
Matruh EgAn 1047–61 o20 o20 o20 80 o
Gamboa MARU 10962 o20 o20 o20 o20
Ketapang MM 2549 o20 o20 o20 o20 o
Okola YM 50 o20 o20 o20 o20 o
Capim BeAn 8582 o20 o20 o20 o20 o
Hazara PakJC 280 o20 o20 o20 o20 o
Toscana ISS PHL 3 o20 o20 o20 o20 o
Brazoran Original o20 o20 o20 o20 o
a Antibody abbreviations are as follows: BWA¼Bwamba, GMA¼Guama, ANA¼Anop
BRAZ¼Brazoran.
b A detailed description of the viruses that the listed bunyavirus antibodies were p
Table 3
Summary of Brazoran virus genome segment sizes, genomic organization, and individu
Segment Size ORFa Predicted Predicte
Proteinb MW-kD
L 6911 45–6785 Pol 261
M 4659 59–4429 Gn-NSm-Gc 165.3
Gn (18–301)e 32.7
NSm (302–515) 24.2
Gc (516–1456) 106.4
S 1672 31–549 NSs 19.6
72–1400 N 49.8
a Open reading frame genome positions based upon plus/message sense of the segm
b Abbreviations of the viral proteins; pol¼RNA dependent RNA polymerase, NS
N¼nucleocapsid protein, ND¼not determined.
c Protein sizes determined by electrophoresis on 10–20% novex denaturing polya
treatment with protein deglycosidases prior to electrophoresis.
d Proteins were identiﬁed by mass spectrometry as described in materials and the
considered deﬁnitive identiﬁcation.
e Amino acid position of the polyprotein.
20
120
80
60
50
40
30
100 G1
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G2
1 2 3 4
Fig. 2. A–B. Identiﬁcation of Brazoran virus structural proteins by polyacrylamide gel
Brazoran virus on a 10–20% Tris-Glycine gel. Lane 1, molecular weight standards; lane 2, u
4, 1:10 dilution of gradient puriﬁed virus treated with de-glycosylation enzymes. Band
identiﬁed by mass spectrometry analysis. (B) Mascot Software (Matrix Science) analysisligated to the DNA library using the Ion Xpress Amplicon Library
Kit (Life Technologies) following the manufacturer's protocol.
Sequencing templates containing clonally ampliﬁed DNA wereus, nairovirus and phlebovirus viruses and antibodies.
BRAZ
roup 2 Group 3 Group 12 CAP CCHF PHL
20 o20 o20 o20 o20 o20 o20
20 o20 o20 o20 o20 o20 o20
20 o20 o20 o20 o20 o20 o20
20 o20 o20 o20 o20 o20 o20
320 o20 o20 o20 o20 o20 o20
20 440960 o20 o20 o20 o20 o20
20 o20 640 o20 o20 o20 o20
20 o20 o20 160 o20 o20 o20
20 o20 o20 o20 40 o20 o20
20 o20 o20 o20 o20 640 o20
20 o20 o20 o20 o20 o20 640
heles, CAP¼Capim, CCHF¼Crimean Congo hemorrhagic fever, PHL¼Phlebotomus,
repared against is included in Materials and methods.
al segment protein products.
d Predicted PAGE MW PAGE MW ID by
a GLY sites nativec GLY-c MSd
14 ND ND ND
2 37 kD 35 kD YES (9)
2 ND ND ND
5 135 kD 110 kD YES (48)
2 ND ND ND
0 50 kD 50 kD YES (27)
ents.
m¼M segment non-structural protein, NSs¼S segment non-structural protein,
crylamide gels; native indicates gradient puriﬁed virus untreated, GLY- indicates
number in parenthesis indicates The number of unique peptide matches, 43 is
electrophoresis and mass sprectrometry. (A) Electrophoresis of gradient puriﬁed
ndiluted gradient puriﬁed virus; lane 3, 1:10 dilution of gradient puriﬁed virus; lane
s labeled as G1 (glycoprotein 1), NC (nucleocapsid), and G2 (glycoprotein 2) were
results from mass spectrometry of excised 50 kD putative NC protein band.
Fig. 3. a–c. Phylogenies of the S, M and L segments of the genus Orthobunyavirus. According to a limited diversity of data that are available in GenBank, neighbor-joining
methods were used to derive phylogenies from (a) nucleocapsid, (b) partial glyco- and (c) polymerase protein amino acid sequences of selected orthobunyaviruses along
with members of the Hantavirus, Nairovirus and Phlebovirus genera. Scale bars represent the number of nucleotide substitutions per site.
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R.S. Lanciotti et al. / Virology 444 (2013) 55–6362prepared using the Ion OneTouch 200 Template Kit and the Ion
OneTouch instrument following the manufacturer's protocols (Life
Technologies). The enriched Ion Sphere particles were sequenced
on the Ion PGM with the Ion PGM 200 sequencing kit and utilizing
an Ion 316 chip (Life Technologies) according to the manufacturer's
protocol. The sequencing run generated 3.7 million reads with an
average read length of 125 bases. The sequence reads were
analyzed and contiguous sequences (contigs) generated using
the DeNovo assembly algorithm within the CLC bio Genomics
Workbench software package (CLC bio). Over 16,000 contigs were
generated and the top 500 contigs with the longest read length
and the greatest number of read sequences were subjected to
BLAST analysis performed on the NCBI website (http://www.ncbi.
nlm.nih.gov/). The 5′ and 3′ terminal ends of each viral genome
segment were determined by using the Invitrogen 5′/3′ RACE
System kits (Life Technologies) following the manufacturer's pro-
tocol to generate the DNA templates followed by capillary sequen-
cing on an ABI 3130 instrument (Life Technologies). Analysis of the
predicted protein sequences for post-translation modiﬁcations,
family domains, functional motifs, and predicted cleavage sites
was performed with InterProScan and Motif Scan on the European
Bioinformatics Institute (EBI) website (http://www.ebi.ac.uk/).Real time ﬂuorescent probe based RT-PCR
Real time primers and FAM labeled probes were designed for
each viral RNA segment using the free software Primer3Plus
website and the newly derived sequence data (Table 1). Real time
assays were performed using the QIAGEN QuantiTect Probe RT-
PCR kit (Qiagen) following the kit's protocol for cycling times and
temperatures. To estimate the quantity of virus present in various
samples (i.e. for virus growth analysis), a standard curve was
generated in which virus dilutions were quantitated by plaque
assay and tested in parallel by real time RT-PCR analysis. Utilizing
the linear equation generated from the standard curve with
experimentally derived Ct values from unknown specimens, an
estimate of the number of pfu in a given sample is derived. In
addition, standard curves were also generated for the M and S
segments using single stranded RNA templates transcribed in vitro
and quantitated in the Agilent Bioanalyzer. Using these templates,
the number of genome copies within a sample could be calculated.N
Brazoran
NSs
N
NSs
~1.La Crosse
amino portion
of relative 
homology
Fig. 4. A–B. Comparison of S segment vcRNA coding strategies and alignment of N
organization and protein composition, La Crosse virus was chosen as generally represen
are drawn as a general depiction of organization and are not drawn to scale. Alignments o
www.ncbi.nlm.nih.gov/tools/cobalt/. Regions of the Brazoran virus N protein possessingIn vitro transcription and translation
5′ and 3′ terminal primers were designed for the viral genome
M and S segments using Primer3Plus software (http://www.
bioinformatics.nl/primer3plus). The 5′ primers possessed an addi-
tional 19 base T7 promoter sequence at the 5′ end which was
incorporated during the RT-PCR reaction. RT-PCR was performed
using these terminal primers and the Invitrogen SuperScripts
One-Step RT-PCR System for Long Templates (Life Technologies).
DNA templates were puriﬁed and RNA transcribed, a 5′ cap added,
and a poly-A tail added with the Ambion mMESSAGE
mMACHINEs T7 ULTRA Kit (Invitrogen). The resulting message
sense RNA was used as a template for in vitro translation in the
Promega Transcend™ Colorimetric Translation Detection System
(Promega) incorporating biotinylated lysine as the protein label.
The translation products were electrophoresed in a novex 10–20%
Tris-Glycine gel. Proteins were transferred to a PVDF membrane
using the Invitrogen iBlot system (Invitrogen). In vitro translated
biotin labeled proteins were visualized using streptavidin alkaline
phosphatase in the Thermo Scientiﬁc Biotin Chromogenic Detec-
tion Kit (Thermo Scientiﬁc) according to the kit protocol.Phylogenetic analyses
S, M and L segment phylogenetic analyses were conducted on
Brazoran virus and other virus strains representing the serological
diversity of the of genus Orthobunyavirus that has been described
at the genetic level along with representatives of the other three
animal-infecting genera of the family Bunyaviridae (Fig. 3a–c).
Alignments of the nucleocapsid, glyco- and polymerase protein
amino acid sequences were generated using the Clustal W
(Thompson et al., 1994) function of MEGA version 5 software
(Tamura et al., 2011). Alignments of the S and L segments were
based upon full length amino acid sequence alignments. The
alignment of the M segment was conducted on truncated amino
sequences (∼400 aa) that reﬂect the broadest diversity of available
M segment coding data that are available in GenBank. Neighbor-
Joining (NJ) trees were generated and analyzed with 2000 repli-
cates for bootstrap testing (Tamura et al., 2011). Generated trees
are presented here (Fig. 3a–c).~1.7kb
0kb
novel
glutamine-rich
carboxyl portion
proteins of Brazoran and La Crosse viruses. To highlight differences in genomic
tative of known orthobunyaviruses for comparison. Viral complementary RNAs (A)
f the Brazoran and La Crosse N proteins (B) were conducted using COBALT at http://
a relatively high number of glutamine residues appear in boxes.
R.S. Lanciotti et al. / Virology 444 (2013) 55–63 63Acknowledgments
We gratefully acknowledge Mary D'Anton and the Texas
Department of State Health Services Arbovirus-Entomology Team
for isolating the three strains of Brazoran virus. We thank Jason
Velez for production of cells used in this study.
References
Beaty, B.J., Sundin, D.R., Chandler, L.J., Bishop, D.J., 1985. Evolution of bunyaviruses
by genome reassortment in dually infected mosquitoes (Aedes triseriatus).
Science 230, 548–550.
Blakqori, G., Delhaye, S., Habjan, M., Blair, C.D., Sanchez-Vargas, I., Olson, K.E.,
Attarzadeh-Yazdi, G., Fragkoudis, R., Kohl, A., Kalinke, U., Weiss, S., Michiels, T.,
Staeheli, P., Weber, F., 2007. La Crosse bunyavirus nonstructural protein NSs
serves to suppress the type I interferon system of mammalian hosts. J. Virol. 81,
4991–4999.
Borucki, M.K., Chandler, L.J., Parker, B.M., Blair, C.D., Beaty, B.J., 1999. Bunyavirus
superinfection and segment reassortment in transovarially infected mosqui-
toes. J. Gen. Virol. 80, 3173–3179.
Bowen, M.D., Trappier, S.G., Sanchez, A.J., Meyer, R.F., Goldsmith, C.S., Zaki, S.R.,
Dunster, L.M., Peters, C.J., Ksiazek, T.J., Nichol, S.T., 2001. A reassortant
bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia.
Virology 291, 185–190.
Briese, T., Bird, B., Kapoor, V., Nichol, S.T., Lipkin, W.I., 2006. Batai and Ngari viruses:
M segment reassortment and association with severe febrile disease outbreaks
in East Africa. J. Virol. 80, 5627–5630.
Bridgen, A., Weber, F., Fazakerley, J.K., Elliott, R.M., 2001. Bunyamwera bunyavirus
nonstructural protein NSs is a nonessential gene product that contributes to
viral pathogenesis. Proc. Nat. Acad. Sci. U.S.A. 98, 664–669.
Campbell, G.R., Pasquier, E., Watkins, J., Bourgarel-Rey, V., Peyrot, V., Esquieu, D.,
Barbier, P., de Mareuil, J., Braguer, D., Kaleebu, P., Yirrell, D., Loret, E., 2004. The
glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis.
J. Biol. Chem. 46, 48197–48204.
Gerrard, S.R., Li, L., Barrett, A.D., Nichol, S.T., 2004. Ngari virus is a Bunyamwera
virus reassortant that can be associated with large outbreaks of hemorrhagic
fever in Africa. J. Virol. 78, 8922–8926.
Hang, J., Forshey, B., Kochel, T., Li, T., Fiestas Solórzano, V., Halsey, E., Kuschner, R.,
2012. Random ampliﬁcation and pyrosequencing for identiﬁcation of novel
viral genome sequences. J. Biomol. Technol. 23, 4–10.
Hoffmann, B., Scheuch, M., Höper, D., Jungblut, R., Holsteg, M., Schirrmeier, H.,
Eschbaumer, M., Goller, K.V., Wernike, K., et al., 2011. Novel orthobunyavirus in
Cattle, Europe, 2011. Emerg. Infect. Diseases 18, 469–472.
Johnson, B.W., Kosoy, O., Hunsperger, E., Beltran, M., Delorey, M., Guirakhoo, F.,
Monath, T., 2009. Evaluation of chimeric Japanese encephalitis and dengueviruses for use in diagnostic plaque reduction neutralization tests. Clin. Vaccine
Immunol. 16, 1052–1059.
Kohl, A., Clayton, R.F., Weber, F., Bridgen, A., Randall, R.E., Elliott., R.M., 2003.
Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory
factor 3-mediated induction of early cell death. J. Virol. 77, 7999–8008.
Kuno, G., 1998. Universal diagnostic RT-PCR protocol for arboviruses. J. Virol.
Methods 72, 27–41.
Lambert, A.J., Lanciotti, R.S., 2008. Molecular characterization of medically impor-
tant viruses of the genus Orthobunyavirus. J. Gen. Virol. 89, 2580–2585.
Lambert, A.J., Lanciotti, R.S., 2009. Consensus ampliﬁcation and novel multiplex
sequencing method for S segment species identiﬁcation of 47 viruses of the
Orthobunyavirus, Phlebovirus, and Nairovirus genera of the family Bunyavir-
idae. J. Clin. Microbiol. 47, 2398–2404.
Landeras-Bueno, S., Jorba, N., Pérez-Cidoncha, M., Ortín, J., 2011. The splicing factor
proline-glutamine rich (SFPQ/PSF) is involved in inﬂuenza virus transcription.
PLoS Pathog. 11, e1002397.
McMullan, L.K., Folk, S.M., Kelly, A.J., MacNeil, A., Goldsmith, C.S., Metcalfe, M.G.,
Batten, B.C., Albariño, C.G., Zaki, S.R., Rollin, P.E., Nicholson, W.L., Nichol, S.T.,
2012. A new phlebovirus associated with severe febrile illness in Missouri.
N. Engl. J. Med. 367, 834–841.
Mohamed, M., McLees, A., Elliott, R.M., 2009. Viruses in the Anopheles A, Anopheles
B, and Tete serogroups in the Orthobunyavirus genus (family Bunyaviridae) do
not encode an NSs protein. J. Virol. 83, 7612–7618.
Obijeski, J.F., Marchenko, A.T., Bishop, D.H., Cann, B.W., Murphy, F.A., 1974.
Comparative electrophoretic analysis of the virus proteins of four rhabdo-
viruses. J. Gen. Virol. 22, 21–33.
Suske, G., 1999. The Sp-family of transcription factors. Genetics 238 (2), 291–300,
Oct 1.
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., Kumar, S., 2011. MEGA5:
molecular evolutionary genetics analysis using maximum likelihood, evolu-
tionary distance, and maximum parsimony methods. Mol. Biol. Evol. 10,
2731–2739.
Thompson, J.D., Higgins, D.,G., Gibson, T.J., 1994. CLUSTAL W: improving the
sensitivity of progressive multiple sequence alignment through sequence
weighting, position-speciﬁc gap penalties and weight matrix choice. Nucleic
Acids Res. 22, 4673–4680.
Weber, F., Bridgen, A., Fazakerley, J.K., Streitenfeld, H., Randall, R.E., Elliott, R.M.,
2002. Bunyamwera bunyavirus nonstructural protein NSs counteracts the
induction of alpha/beta interferon. J. Virol. 76, 7949–7955.
Yu, X.J., Liang, M.F., Zhang, S.Y., Liu, Y., Li, J.D., Sun, Y.L., Zhang, L., Zhang, Q.F., Popov,
V.L., Li, C., Qu, J., Li, Q., Zhang, Y.P., Hai, R., Wu, W., Wang, Q., Zhan, F.X., Wang, X.
J., Kan, B., Wang, S.W., Wan, K.L., Jing, H.Q., Lu, J.X., Yin, W.W., Zhou, H., Guan, X.
H., Liu, J.F., Bi, Z.Q., Liu, G.H., Ren, J., Wang, H., Zhao, Z., Song, J.D., He, J.R., Wan,
T., Zhang, J.S., Fu, X.P., Sun, L.N., Dong, X.P., Feng, Z.J., Yang, W.Z., Hong, T., Zhang,
Y., Walker, D.H., Wang, Y., Li, D.X., 2011. Fever with thrombocytopenia
associated with a novel bunyavirus in China. N. Engl. J. Med. 364, 1523–1532.
